Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jun 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1798401000001112 | Fedratinib dihydrochloride monohydrate | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1798421000001117 | Fedratinib dihydrochloride monohydrate (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fedratinib dihydrochloride monohydrate | Is a | Antineoplastic agent | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fedratinib 100mg capsules | Has specific active ingredient | True | Fedratinib dihydrochloride monohydrate | Inferred relationship | Existential restriction modifier | |
| Inrebic 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) | Has specific active ingredient | True | Fedratinib dihydrochloride monohydrate | Inferred relationship | Existential restriction modifier | |
| Inrebic 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) 120 capsule | Has specific active ingredient | True | Fedratinib dihydrochloride monohydrate | Inferred relationship | Existential restriction modifier | |
| Fedratinib 100mg capsules 120 capsule | Has specific active ingredient | True | Fedratinib dihydrochloride monohydrate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR